Abdulkader Rahmo

Abdulkader Rahmo

Company: SMS Biotech

Job title: President and CSO


Minimizing Risk in Regenerative Therapies 3:00 pm

Delivering partial reprogramming to reduce the risk of tumorigenicity Preventing off-target effects and ensuring expression is only seen in the organ of interest Tackling dosage and delivery challenges in regenerative therapiesRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.